key: cord-0030163-ttzj8ml0
authors: Alagarasu, Kalichamy; Patil, Poonam; Kaushik, Meenakshi; Chowdhury, Deepika; Joshi, Rajesh K.; Hegde, Harsha V.; Kakade, Mahadeo B.; Hoti, Sugeerappa Laxmanappa; Cherian, Sarah; Parashar, Deepti
title: In Vitro Antiviral Activity of Potential Medicinal Plant Extracts Against Dengue and Chikungunya Viruses
date: 2022-04-07
journal: Front Cell Infect Microbiol
DOI: 10.3389/fcimb.2022.866452
sha: f6fab2c07d0fd0e51068292d41b31b7b9df382c4
doc_id: 30163
cord_uid: ttzj8ml0

Dengue and chikungunya are two important mosquito-borne infections which are known to occur extensively in tropical and subtropical areas. Presently, there is no treatment for these viral diseases. In vitro antiviral screening of 25 extracts prepared from the plants of Vitex negundo, Plumeria alba, Ancistrocladus heyneanus, Bacopa monnieri, Anacardium occidentale, Cucurbita maxima, Simarouba glauca, and Embelia ribes using different solvents and four purified compounds (anacardic acid, chloroquinone, glaucarubinone, and methyl gallate) were carried out for their anti-dengue virus (DENV) and anti-chikungunya virus (CHIKV) activities. Maximum nontoxic concentrations of the chloroform, methanol, ethyl acetate, petroleum ether, dichloromethane, and hydroalcoholic extracts of eight plants were used. The antiviral activity was assessed by focus-forming unit assay, quantitative real-time RT-PCR, and immunofluorescence assays. Extracts from Plumeria alba, Ancistrocladus heyneanus, Bacopa monnieri, and Cucurbita maxima showed both anti-DENV and CHIKV activity while extract from Vitex negundo showed only anti-DENV activity. Among the purified compounds, anacardic acid, chloroquinone and methyl gallate showed anti-dengue activity while only methyl gallate had anti-chikungunya activity. The present study had identified the plant extracts with anti-dengue and anti-chikungunya activities, and these extracts can be further characterized for finding effective phytopharmaceutical drugs against dengue and chikungunya.

Dengue and chikungunya virus infections are important causes of morbidity and mortality in tropical and subtropical parts of the world. Dengue virus (DENV) and chikungunya virus (CHIKV) are transmitted through Aedes aegypti and Aedes albopictus mosquitoes. Both of the viruses cause acute febrile illness, and symptoms wise, both diseases are identical in the acute phase, though the clinical presentation differs as the infection progresses (Cecilia, 2014) .

There are no licensed antivirals/vaccines available against DENV and CHIKV, and their prevention is still based on vector control measures. Therefore, the need for effective drugs with anti-dengue and anti-chikungunya activities is imperative. Natural products from herbal plants have shown to be effective against a variety of viral diseases (Jassim and Naji, 2003) . Herbal compounds present an interesting avenue to explore because of their high accessibility in nature and cost effectiveness though safety remains a concern due to lack of sufficient regulatory measures (Ekor, 2014) . Moreover, plant extracts are a better source of novel chemical structures with medicinal property which can be exploited to make synthetic drugs with superior activity and reduced toxicity (Choodej et al., 2018) . A concerted search involving 3,789 samples from 3,482 plants belonging to 233 families against Ranikhet disease virus, vaccinia virus, Japanese encephalitis virus, and Semiliki forest virus resulted in identifying 242 samples from 96 families with antiviral activity (Dhawan, 2012) . A number of plants such as Rhapis excels, Vernonia amygdalina, Trigonostemon cherrieri, Anacolosa pervilleana, and Melia azedarach L have been reported to possess inhibitory activity against CHIKV (Allard et al., 2012; Bourjot et al., 2012; Sangeetha and Rajarajan, 2015; Chan et al., 2016) . Plantderived compounds such as nobiletin, epigallocatechin-3-gallate, silymarin, curcumin, and harringtonine were reported to have anti-chikungunya activity (Kaur et al., 2013; Lani et al., 2015; Weber et al., 2015; von Rhein et al., 2016; Lin et al., 2017; Mounce et al., 2017) . Some other plants like Cocculus hirsutus, Cissampelos pareira, Euphorbia hirta, Andrographis paniculata, Momordica charantia and Leucas cephalotes have been reported to exert antiviral activity against DENV (Tang et al., 2012; Sood et al., 2015; Rajasekaran et al., 2016; Perera et al., 2018; Kaushik et al., 2021; Shukla et al., 2021) .

Though a number of plants have been tested for the antiviral activity, it would be worth investigating other plants that have been used in the age-old practices in Ayurveda, which is a traditional form of Indian medicine. In Ayurvedic form of medicine, a group of herbs are combined into formulations called Rasayana which is provided to enhance the body's resistance to infections and other diseases (Singh et al., 2021) . There is a need to study the antiviral activity of those herbs which are used in traditional forms of medicine for which not much scientific evaluations have been carried out. Furthermore, it would be important to evaluate the Indian alternatives to the plants that are not native to India having anti-dengue and antichikungunya activities. Therefore, in this study, extracts prepared using seven plants with medicinal properties ( Table 1) but not tested for their antiviral activity against dengue and chikungunya were investigated for their activity against dengue and chikungunya virus.

Vero (ATCC No. CCL-81) cell line was maintained using MEM (Himedia, Mumbai, India), supplemented with 10% FBS (Gibco, USA), and antibiotic-antimycotic solution (Sigma-Aldrich, Saint Louis, MO, USA) at 37°C and 5% CO 2 . Dengue virus (DENV) serotype-2 (Strain No. 803347) and chikungunya (CHIKV, Strain No. 061573, P-2, African genotype) were used for this study. DENV-2 stock was prepared in C6/36 (mosquito cell line) and CHIKV was propagated in Vero cells and stored at −80°C.

A total of 25 different parts from eight plants, i.e., Vitex negundo (RMRC-1355), Plumeria alba (RMRC-1357), Ancistrocladus heyneanus (RMRC-1359), Bacopa monnieri (RMRC-1361), Anacardium occidentale (RMRC-1356), Cucurbita maxima (RMRC-1362), Simarouba glauca (RMRC-1358), and Embelia ribes (RMRC-1360) ( Table 1) , selected based on their ethno botanical use in the treatment of infectious diseases, were collected from various sites in Belagavi, identified, and authenticated at ICMR-National Institute of Traditional Medicine, Belagavi, where voucher herbarium specimens were deposited. Four purified compounds, i.e., anacardic acid (Sigma-Aldrich, Saint Louis, MO, USA), chloroquinone (Sigma-Aldrich, Saint Louis, MO, USA), methyl gallate (Sigma-Aldrich, Saint Louis, MO, USA), and glaucarubinone (Dr. John Beutler's Lab, NIH USA) were also included in this study.

Plant parts (leaves, bark, seeds, and whole herbs) were airdried, ground to powder, and macerated in different solvents such as ethanol ( 

A total of 25 extracts and four purified compounds were used for further screening (Table 1) . Extracts and stock solutions of purified compounds (1 mg/ml) were prepared by diluting extracts and compounds in different solvents, i.e., petroleum ether, methanol, ethanol, and dimethyl sulfoxide (0.1%) and purified by filtering through a syringe filter (pore size = 0.2 µM), and the solutions were preserved at −20°C until use.

The cytotoxicity effect of the extracts and the compounds was evaluated by 3-(4,5-dimethythiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay as described previously (Parashar et al., 2013) . Briefly, monolayers of Vero cells in 96well plates were incubated with different concentrations (0 to 200 µg/ml) of test formulations for 5 days at 37°C, incubated with MTT solution (5 mg/ml) for an additional 3 h at 37°C. The solubilized formazan crystals were measured using a microplate reader (BioTek Synergy, USA) at 570 nm. The percentage inhibition and CC50 values were calculated.

All the extracts at their maximum nontoxic dose were assayed for their antiviral activity against DENV and CHIKV under posttreatment condition as described earlier (Panda et al., 2021; Patil et al., 2021) .

The extracts which showed antiviral activity were further tested at different concentrations for their antiviral activity under all the three treatment conditions (pre-, co-, and posttreatment) as described earlier (Panda et al., 2021; Patil et al., 2021) .

During pretreatment, the cells were pretreated with a formulated extracts at 37°C for 24 h followed by removal of the culture supernatant, the cells were then infected either with DENV-2 or CHIKV and incubated for 1 h at 37°C. Any unbound virus particles were removed by PBS, washed two times, and incubated after the addition of maintenance media (MEM with antibiotics and 2% FBS).

In cotreatment, the virus was mixed with different concentrations of the formulated extracts and the mixture was used for infecting cells for a duration of 1 h.

For posttreatment, the cells were infected with DENV-2 or CHIKV for 1 h and treated with the formulated extracts after 24 h.

For all treatments, the plates were incubated after infection for 120 h in the case of DENV-2 and 48 h for CHIKV. After incubation, the plates were frozen at −80°C and thawed to collect Irrespective of the type of treatment, 0.1 multiplicity of infection (MOI) of DENV-2 or 0.01 MOI of CHIKV was used for infection. MOI was calculated on the basis of number of cells used for seeding the wells.

The tissue culture supernatants collected from the different wells treated under different conditions were assessed for viral genomic RNA using quantitative real-time RT-PCR and infectious virus particle titer using FFU assay. The percent of cells infected was assessed using immunofluorescence assay (IFA).

Detection and quantitative estimation of viral genomic RNA was done using quantitative real-time RT-PCR assay. The primers and probes used for amplifying DENV-2 and CHIKV and PCR conditions have been described earlier (Panda et al., 2021; Patil et al., 2021) . The viral RNA load of the samples were calculated based on a standard graph generated using cycle threshold values of tenfold dilutions of in vitro transcribed viral RNA with known copy numbers. IFA and FFU assays for DENV-2 and CHIKV were performed as described earlier.

The virus output was measured in terms of FFU/ml or viral RNA copies/ml. The test conditions were compared with virus control using one-way ANOVA followed by multiple comparisons. A p-value of less than 0.05 was considered significant. All analyses were performed using GraphPad Prism software version 7.

In this study, chloroform, methanol, ethyl acetate, petroleum ether, dichloromethane, and hydroalcoholic extracts of eight plants (Vitex negundo, Plumeria alba, Ancistrocladus heyneanus, Bacopa monnieri, Anacardium occidentale, Cucurbita maxima, Simarouba glauca, and Embelia ribes) were tested for their antiviral activity against DENV and CHIKV. The profile of the medicinal plants used in this study is listed in Table 1 .

Potential cytotoxic effects of the 25 extracts and four purified compounds were determined using the MTT assay in Vero CCL-81 cells. Three extracts (M8E, M8M, and M9M) and one purified compound (G-S) showed no cytotoxicity ( Table 1) . The CC50 values of the different extracts are given in Table 1 . The concentration of the extract which allowed around 80% cell viability was further used for studying the antiviral activity. The cutoff of 80% viability was decided as per earlier literature (ISO 10993-5:2009; Wang et al., 2018) . The effect of different extracts at different concentrations on cell viability with CC50 values is provided in Supplementary Figure S1.

The plant extracts were screened by assessing their antiviral activity against DENV and CHIKV postinfection. FFU assay was used to measure the titer of the virus. The highest nontoxic dose (which allowed around 80% cell viability) was used for all extracts. Out of 25 extracts and four purified compounds, five extracts (M2C, M8M, M4C, M5C, and M7M) and three purified compounds [anacardic acid (A-S), chloroquinone (C-S), and methyl gallate (MG-S)] showed significant reduction (≥1 log 10 reduction) in the titer of DENV compared with virus control (infected cells without any treatment) ( Figure 1A ). Four extracts (M8M, M5C, M7M, and M9M) and one purified compound (MG-S) affected CHIKV titer ( Figure 1B and Table 2 ).

Chloroform extract of Plumeria alba bark (M2C) and methanol extract of Plumeria alba (M8M) were processed to check their prophylactic (pretreatment effect), virucidal (cotreatment effect), and therapeutic (posttreatment effect) activities at concentrations of ≤7.8 and ≤250 mg, respectively, and the virus titer was determined by FFU assay and viral RNA by quantitative real-time RT-PCR. Both M2C and M8M did not show any anti-DENV activity under pretreatment condition (Figures 2A, C) . Under cotreatment condition, M2C exerted significant one log (5.451 to 4.429 mean log 10 FFU/ml) reduction at a concentration of 7.8 mg while M8M showed a significant dose-dependent reduction from a concentration of 62.5 mg onwards with two log reductions (5.451 to 3.355 mean log 10 FFU/ml) at 250 mg concentration in DENV titer compared with virus control (Figures 2A, C) . Under posttreatment condition, M2C showed a dose-dependent reduction from 0.975 mg concentration onwards with 100% reduction at a concentration of 7.8 mg in DENV titer compared with virus control (p < 0.0001) ( Figure 2A ). In comparison with virus control, M8M exerted a dosedependent reduction from 125 mg onwards with more than one log reduction (5.108 to 3.822 mean log 10 FFU/ml) at a concentration of 250 mg ( Figure 2C ). Both the extracts did not show any reductions in the viral RNA titer as assessed by quantitative real-time RT-PCR under all conditions ( Figures 2B, D) .

In the case of chikungunya, 250 mg methanol extract of Plumeria alba leaves (M8M) showed 100% reduction of CHIKV titer under pre-and posttreatment conditions compared with virus control (p < 0.0001). The effect was more pronounced under posttreatment condition, and a significant dose-dependent reduction was observed from with 31.25 mg onwards compared with virus control (p < 0.0001) ( Figure 3A) . Quantitative real-time RT-PCR results revealed a significant reduction in viral RNA titer under both pre-and posttreatment conditions at concentration of 250 and 125 mg, respectively, compared with the untreated ( Figure 3B ) ones. A lack of anti-chikungunya activity was observed under cotreatment condition at the level of viral RNA and focusforming units (p > 0.05) ( Figures 3A, B) .

The chloroform extract of Vitex negundo leaves showed more than two log reductions of DENV titer in case of cotreatment (5.451 to 3.019 mean log 10 FFU/ml) and posttreatment (5.108 to 2.883 mean log 10 FFU/ml) compared with respective virus controls at 7.8 mg concentration ( Figure 4A ). The antiviral effect was more pronounced under posttreatment condition and a dose-dependent inhibitory effect on virus was observed from 1.958 mg concentration onwards. Quantitative real-time RT-PCR results revealed that the extract had no effect on viral RNA titer under all conditions (Figure 4B) , and a significant reduction was observed for viral RNA using quantitative realtime RT-PCR ( Figure 4B) . The extract lacked anti-CHIKV activity. , and after the incubation, the plates were frozen and the culture filtrates were used for the different assays. The experiments were performed at two independent time points in triplicates, and the results are expressed as mean log 10 focus-forming unit/ml ± standard error. All the treatment conditions were compared with the virus control. ****p < 0.0001. 

Anti-dengue and anti-chikungunya activities of chloroform extract of Ancitrocladus heyeanus bark was investigated under pre-, co-, and posttreatment conditions at concentrations of ≤3.9 mg which is the maximum nontoxic concentration. The results revealed that the extract had a dose-dependent anti-DENV activity from 0.49 mg onwards under posttreatment condition. Complete reduction in viral titer was observed at 1.95 and 3.9 mg concentrations ( Figure 5A ). Though not prominent as infectious virus particles, a reduction in viral RNA titer was observed from 1.95 mg onwards ( Figure 5B ). For chikungunya, M5C at a concentration of 3.9 mg showed a reduction in viral titer from 7.563 to 2.430 mean log 10 FFU/ml under posttreatment condition. However, similar reduction in viral RNA titer was not observed. The extract lacked antichikungunya activity under pre-and cotreatment conditions ( Figures 6A, B) .

Under cotreatment condition, hydroalcoholic extract of Bacopa monnieri whole herb (M7M) reduced the DENV titer starting from 62.5 mg onwards with a maximum reduction (5.451 to 3.264 mean log 10 FFU/ml) at 125 mg under cotreatment condition. The anti-dengue activity was more pronounced under posttreatment condition with a reduction starting from 15.62 mg, and a complete reduction of DENV titer was observed from 62.5 mg onwards ( Figure 7A) . However, the corresponding reduction in viral RNA titer was not observed for both co-and posttreatment conditions ( Figure 7B ).

In the case of chikungunya, more than one log reduction (7.563 to 6.451 mean log 10 FFU/ml) under posttreatment condition was observed at the maximum nontoxic concentration of 125 mg ( Figure 8A) . No significant reduction of viral RNA was observed for viral RNA under all conditions ( Figure 8B ).

Methanol extract of Cucurbita maxima seeds (M9M) exerted anti-chikungunya activity under all conditions. The antiviral effect was observed under pre-and posttreatment conditions at concentrations above 125 µg with complete reduction in viral titer ( Figure 9A ). Under cotreatment condition, complete reduction in viral titer was observed at 250 µg concentration. Corresponding reduction in CHIKV RNA titer was also observed under all conditions though not as the same extent to that infectious virus titer ( Figure 9B ).

Among the pure compounds, A-S exerted anti-dengue activity under pre-and posttreatment conditions. The effect was prominent under posttreatment condition in which the antidengue activity was observed from 7.8 µg onwards with complete reduction in infectious virus titer from 15.62 µg onwards. Under pretreatment condition, the mild reduction in virus titer was observed at concentrations of 31.25 and 62.5 µg ( Figure 10A) . A mild but significant reduction in DENV RNA titer was observed under posttreatment condition at 62.5 µg (p < 0.0001) ( Figure 10B ). Anacardic acid did not exert antichikungunya effect.

C-S exerted anti-dengue activity under all three conditions. Under pretreatment condition, the activity was observed from 62.5 µg onwards while under cotreatment condition, the activity was observed at 250 µg. The anti-dengue activity was more prominent under posttreatment condition in which anti-dengue activity was observed from 31.25 µg onwards with complete inhibition of virus titer from 61.25 µg onwards ( Figure 10C) . A significant decrease in DENV RNA titer was also observed under pre-and posttreatment conditions though not as prominent as the decrease in infectious virus titer was observed ( Figure 10D ). Chloroquinone did not show any anti-chikungunya activity.

MG-S decreased DENV titer in a dose-dependent manner from 0.975 µg onwards and a 100% reduction in FFU was observed compared with virus control at concentrations of 3.9 and 7.8 µg under posttreatment condition. Under pretreatment and cotreatment conditions, a mild reduction in FFU titer was observed at 7.8 µg ( Figure 10E ).

In the case of chikungunya, methyl gallate exerted a mild reduction virus titer in terms of FFU and viral RNA at a concentration of 7.8 µg under posttreatment conditions ( Figures 11A, B) . . The experiments were performed at two independent time points in triplicates, and the results are expressed as either mean log 10 focus-forming unit/ml ± standard error (A) or mean log 10 viral RNA copies/ml ± standard error (B). All the treatment conditions were compared with the virus control. ****p < 0.0001.

FIGURE 4 | Antiviral effect of leaves of Vitex negundo chloroform extract (M4C) against DENV under different treatment conditions. Vero CCL-81 cells were pre-, co-, and posttreated with different concentrations of extracts, and 120 h incubation after infection, the plates were frozen and the culture filtrates were used for the FFU assay (A) and real-time PCR (B). The experiments were performed at two independent time points in triplicates, and the results are expressed as mean log 10 focus-forming unit/ml ± standard error as well as mean log 10 viral RNA copies/ml ± standard error. All the treatment conditions were compared with the virus control. ****p < 0.0001; ***p < 0.001; **p < 0.005. 

Dengue and chikungunya diseases are serious public health problems, and the unavailability of antivirals make these diseases a concern. Traditionally, plants have been used to treat various diseases including viral diseases for centuries (Herrmann et al., 2011; Ogbole et al., 2018) . Therefore, plant-based anti-chikungunya and anti-dengue A B FIGURE 5 | Antiviral effect of bark of Ancitrocladus heyneanus chloroform extract (M5C) against DENV under different treatment conditions. Vero CCL-81 cells were pre-, co-, and posttreated with different concentrations of extracts, and 120 h incubation after infection, the plates were frozen and the culture filtrates were used for the FFU assay (A) and real-time PCR (B). The experiments were performed at two independent time points in triplicates, and the results are expressed as either mean log 10 focus-forming unit/ml ± standard error (A) or mean log 10 viral RNA copies/ml ± standard error (B). All the treatment conditions were compared with the virus control. ****p < 0.0001.

FIGURE 6 | Antiviral effect of bark of Ancitrocladus heyneanus chloroform extract (M5C) against CHIKV under different treatment conditions. Vero CCL-81 cells were pre-, co-, and posttreated with different concentrations of extracts, and 48 h incubation after infection, the plates were frozen and the culture filtrates were used for the FFU assay (A) and real-time PCR (B). The experiments were performed at two independent time points in triplicates, and the results are expressed as either mean log 10 focus-forming unit/ml ± standard error (A) or mean log 10 viral RNA copies/ml ± standard error (B). All the treatment conditions were compared with the virus control. ****p < 0.0001. drugs might be an alternative option to treat these mosquitoborne diseases.

In the present study, chloroform, methanol, ethyl acetate, hydro-alcoholic, petroleum ether, and dichloromethane extracts of five selected plant species (Plumeria alba, Ancistrocladus heyneanus, Bacopa monnieri, Curcubita maxima, Vitex negundo) were tested for their antiviral activity against DENV and CHIKV. Out of 25 extracts and four purified compounds, A B FIGURE 7 | Antiviral effect of whole herb of Bacopa monnieri hydroalcoholic extract (M7M) against DENV under different treatment conditions. Vero CCL-81 cells were pre-, co-, and posttreated with different concentrations of extracts, and 120 h incubation after infection, the plates were frozen and the culture filtrates were used for the FFU assay (A) and real-time PCR (B). The experiments were performed at two independent time points in triplicates, and the results are expressed as either mean log 10 focus-forming unit/ml ± standard error (A) or mean log 10 viral RNA copies/ml ± standard error (B). All the treatment conditions were compared with the virus control. ****p < 0.0001.

FIGURE 8 | Antiviral effect of whole herb of Bacopa monnieri hydroalcoholic extract (M7M) against CHIKV under different treatment conditions. Vero CCL-81 cells were pre-, co-, and posttreated with different concentrations of extracts, and 48 h incubation after infection, the plates were frozen and the culture filtrates were used for the FFU assay (A) and real-time PCR (B). The experiments were performed at two independent time points in triplicates, and the results are expressed as mean log 10 focus-forming unit/ml ± standard error as well mean log 10 viral RNA copies/ml ± standard error. All the treatment conditions were compared with the virus control. ****p < 0.0001. The chloroform extract from Plumeria alba bark (M2C) showed 100% activity against DENV under posttreatment conditions and methanol extract from Plumeria alba leaves (M8M) showed 100% activity against CHIKV. The results suggest the therapeutic utility of Plumeria alba against both of these viruses. Since hydroalcoholic extracts of Plumeria alba leaves have been reported to possess antiarthritic activity, it might also be useful in reducing arthritis in CHIKV-infected patients (Choudhary et al., 2014b) . Earlier, the inhibitory activity of Plumeria rubra containing fulvoplumierin against human immunodeficiency virus type 1 (HIV) reverse transcriptase has been reported (Tan et al., 1991) . Plumericin compounds isolated from Plumeria species have been reported to inhibit Leishmania donovani and Candida species Singh et al., 2011) . Plumeria alba is known to have various chemical substances including compounds with sterol-like structures like taraxerol, lupeol, betuline, coumarone, and fulvoplumericin which could contribute to antiviral activity and need further investigations (Anggoro et al., 2020) .

Whole herb of Bacopa monnieri (M7M) also showed a significant reduction of DENV and CHIKV titers under posttreatment conditions. Bacopa monnieri, commonly known as Brahmi, is commonly used in the Indian traditional system of medicine as a memory enhancer (Shinomol et al., 2012) . It also has been reported to possess anti-inflammatory, analgesic, antipyretic, sedative, and antiepileptic properties (Saini et al., 2012) . Bacopa monnieri has been reported to contain bacosides and cucurbitacins which have medicinal properties and needs to be investigated for antiviral activity (Bhandari et al., 2007; Banerjee et al., 2021) . Extract from Ancitrocladus heyneanus bark (M5C) showed total reduction of viral foci of DENV and significant activity against CHIKV. Plant from Ancistrocladus genus has been shown to have anticancer, anti-HIV, antimalarial, and antibacterial activities (Karn et al., 2014) . Ancitrocladus heyaneanus is reported to have ancisheynine 1 and betulinic acid among which betulinic acid possesses anti-dengue activity (Bringmann et al., 1996; Bringmann et al., 1997; Loe et al., 2020) .

Leaves of Vitex negundo (M4C) showed a significant reduction of DENV, while no significant activity was found against CHIKV. The ethanolic extract of Vitex negundo has been reported to inhibit the Asian genotype strain of CHIKV (Kothandan and Swaminathan, 2014) . However, in the present study, ECSA genotype of CHIKV was used. A flavone named vitexicarpone, ursolic acid, and betulinic acid have been isolated from Vitex negundo leaves, and the presence of betulinic acid might explain its anti-dengue activity (Chandramu et al., 2003 , Dıáz et al., 2003 .

Seeds of Curcubita maxima (M9M) showed a 100% reduction in the case of CHIKV. Cucurbita leaves contain iron and vitamins (Orech et al., 2007; Nwaoguikpe et al., 2013) and have been reported to possess the potential to treat anemia and sickle cell anemia (Manokaran et al., 2010; Nwaoguikpe et al., 2013) . Curcubita maxima seeds are also known to exert anti-platelet activity (Sanzana et al., 2021) .

The purified compounds viz. anacardic acid, chloroquinone, and methyl gallate showed significant reduction in the case of A B FIGURE 9 | Antiviral effect of Cucurbita maxima seed methanol extract (M9M) against CHIKV under different treatment conditions. Vero CCL-81 cells were pre-, co-, and posttreated with different concentrations of extracts, and 48 h incubation after infection, the plates were frozen and the culture filtrates were used for the FFU assay (A) and real-time PCR (B). The experiments were performed at two independent time points in triplicates, and the results are expressed as either mean log 10 focus-forming unit/ml ± standard error (A) or mean log 10 viral RNA copies/ml ± standard error (B). All the treatment conditions were compared with the virus control. ****p < 0.0001; ***p < 0.001. DENV, while only methyl gallate showed a significant activity in the case of CHIKV. Earlier reports have shown that these compounds exert anti-dengue, antihelmintic, and antiparasitic effects (Hundt et al., 2015) . Anacardic acid is obtained from Anacardium occidentale nuts. However, extracts prepared from Anacardium occidentale leaves did not show any antiviral activity, suggesting absence of active antiviral compounds in leaves. The present study suggests the use of methyl gallate as a standard for investigations of anti-chikungunya activity. Plant extracts which show activity in pretreatment might modulate the host factors such as receptors to prevent virus entry and/or virus replication. The extracts which showed activity under cotreatment conditions might bind to the virus and prevent its binding to the cellular receptors for entry. The A B FIGURE 11 | Antiviral effect of pure compound methyl gallate (MG-S) against CHIKV under different treatment conditions. Vero CCL-81 cells were pre-, co-, and posttreated with different concentrations of pure extract, and 48 h incubation after infection, the plates were frozen and the culture filtrates were used for the FFU assay (A) and real-time PCR (B). The experiments were performed at two independent time points in triplicates, and the results are expressed as either mean log 10 focus-forming unit/ml ± standard error (A) or mean log 10 viral RNA copies/ml ± standard error (B). All the treatment conditions were compared with the virus control. ****p < 0.0001; ***p < 0.001. extracts which showed activity under posttreatment conditions might influence viral replication and/or assembly by interaction with viral proteins or host proteins that take part in these steps. Further studies are needed to find out the mechanism of action of the plant extracts.

In many of these experiments, though antiviral activity was visible in terms of reduction in infectious virus particles (FFU), a corresponding decrease in viral RNA titer was not observed. This suggests that the plant extracts which exerted complete reduction in terms of FFU but not viral RNA may not affect viral RNA replication but might inhibit the assembly of virus particles.

Moreover, quantitative real-time RT-PCR is a more sensitive assay than FFU and detects RNA from even noninfectious particles also. Hence, minor differences in viral RNA titer may be not reflected in quantitative real-time RT-PCR assay results unless there is a major difference in the RNA titer. The extract which affected both FFU and viral RNA titer might inhibit viral RNA replication.

The concentration of the extracts which exerted antiviral activities was different from each other and it is possible that the extracts which had antiviral activity at lower concentrations still had high amount of the active antiviral compound while Anti-Dengue and Anti-Chikungunya Activities of Plants those extracts which exerted antiviral activity at higher concentration had lower amount of the active antiviral compounds. Those extracts which exerted antiviral activity at lower concertation may be further taken forward with whole formulation as a phytopharmaceutical drug while for the extracts which had antiviral activity at higher concentrations, there is a need to identify the active compound to be further considered an antiviral drug. Identifying the active fractions and compounds from the extracts with anti-dengue and anti-chikungunya activities will help to develop the formulations based on the above plants as a phytopharmaceutical drug which can be further evaluated in preclinical and clinical studies. The present study paves the way for further focused research on plant based antivirals against DENV and CHIKV to find effective treatments against these debilitating viral diseases.

The original contributions presented in the study are included in the article/Supplementary Material. Further inquiries can be directed to the corresponding authors.

Conceived and designed the experiments: SC, DP, SH, and KA. Performed the experiments: PP, DC, MK, and MBK. Analyzed the data: DP, KA, PP, DC, MK, HH, MBK, and SC. Provided extracts: SH, RJ, HH, and MK. Wrote the paper: DP, KA, HH, RJ, SC, and SH. All authors listed have made a substantial, direct, and intellectual contribution to the work and approved it for publication.

This work was supported by the ICMR-National Institute of Virology, Pune.

Future Molecular Medicine From White Frangipani (Plumeria alba L.): A Review

Antiviral Chlorinated Daphnane Diterpenoid Orthoesters From the Bark and Wood of Trigonostemon Cherrieri

Bacosides From Bacopa Monnieri Extract: An Overview of the Effects on Neurological Disorders

A Review of Ethnomedicinal Plant-Vitex Negundo Linn

Cucurbitacins From Bacopa Monnieri

Chemical Constituents of Anacolosa Pervilleana and Their Antiviral Activities

Mbandakamines A and B, Unsymmetrically Coupled Dimeric Naphthylisoquinoline Alkaloids, From a Congolese Ancistrocladus Species

Ancistroheynine a, the First 7,8′-Coupled Naphthylisoquinoline Alkaloid From Ancistrocladus Heyneanus

Betulinic Acid: Isolation From Triphyophyllum Peltatum and Ancistrocladus Heyneanus, Antimalarial Activity, and Crystal Structure of the Benzyl Ester

Current Status of Dengue and Chikungunya in India

Investigation of Twenty Selected Medicinal Plants From Malaysia for Anti-Chikungunya Virus Activity

Isolation, Characterization and Biological Activity of Betulinic Acid and Ursolic Acid From Vitex negundo L

Inhibition of TNF-a-Induced Inflammation by Sesquiterpene Lactones from Saussurea lappa and Semi-Synthetic Analogues

Investigation of Antiarthritic Potential of Plumeria Alba L. Leaves in Acute and Chronic Models of Arthritis

Phytochemical and Pharmacological Activity of Genus Plumeria: An Updated Review

Anti-Viral Activity of Indian Plants

The Growing Use of Herbal Medicines: Issues Relating to Adverse Reactions and Challenges in Monitoring Safety

In Vitro Anti-Rotavirus Activity of Some Medicinal Plants Used in Brazil Against Diarrhea

Diversity of Pharmacological Properties in Chinese and European Medicinal Plants: Cytotoxicity, Antiviral and Antitrypanosomal Screening of 82 Herbal Drugs

Antiviral Activity of Embelia Ribes Burm. F. Against Influenza Virus In Vitro

The Inhibitory Effects of Anacardic Acid on Hepatitis C Virus Life Cycle

Novel Antiviral Agents: A Medicinal Plant Perspective

Anti-Proliferative Potential of Phytochemical Fractions Isolated From Simarouba Glauca DC Leaf

Methyl Gallate, Methyl-3,4,5-Trihydoxybenzoate, is a Potent and Highly Specific Inhibitor of Herpes Simplex Virus In Vitro

Antimalarial Activity of Yaoundamine a Naphthyl Iso-Quinoline Alkaloid, Extracted From Stem of Ancistrocladus Heyneanus

Inhibition of Chikungunya Virus Replication by Harringtonine, a Novel Antiviral That Suppresses Viral Protein Expression

Anti-Dengue Activity of Super Critical Extract and Isolated Oleanolic Acid of Leucas Cephalotes Using In Vitro and in Silico Approach

Evaluation of In Vitro Antiviral Activity of Vitex Negundo L

Antiviral Activity of Nobiletin Against Chikungunya Virus In Vitro

Betulinic Acid Exhibits Antiviral Effects Against Dengue Virus Infection

A Critical Review on Medicinally Important Oil Yielding Plant Laxmitaru (Simarouba Glauca DC.)

Haematological Activity of Cucurbita Maxima Linn. Pulp in Phenylhydrazine Induced Anaemic Rats

Curcumin Inhibits Zika and Chikungunya Virus Infection by Inhibiting Cell Binding

The Antisickling Potentials of Four Curcubits (T. Occidentalis, C. Maxima; C. Sativus and C. Lonatus)

Mineral Content of Traditional Leafy Vegetables From Western Kenya

In Vitro Antiviral Activity of a-Mangostin Against Dengue Virus Serotype-2 (Denv-2)

Administration of E2 and NS1 Sirnas Inhibit Chikungunya Virus Replication In Vitro and Protects Mice Infected With the Virus

In Vitro and In Vivo Studies Reveal a-Mangostin, a Xanthonoid From Garcinia Mangostana, as a Promising Natural Antiviral Compound Against Chikungunya Virus

Potential Use of Euphorbia Hirta for Dengue: A Systematic Review of Scientific Evidence

A Systematic Comprehensive Review on Therapeutic Potential of Andrographis Paniculata

Neuroprotective Effects of Bacopa Monnieri in Experimental Model of Dementia

In-Vitro Antiviral Activity of Indian Medicinal Plants to Asian and East Central South African Lineage of Chikungunya Virus

Antiplatelet Activity of Cucurbita Maxima

Effects of Chloroquine on Viral Infections: An Old Drug Against Today's Diseases?

Neuromodulatory Propensity of Bacopa Monnieri Leaf Extract Against 3-Nitropropionic Acid-Induced Oxidative Stress: In Vitro and In Vivo Evidences

Cocculus Hirsutus-Derived Phytopharmaceutical Drug has Potent Anti-Dengue Activity

Ayurveda Rasayana as Antivirals and Immunomodulators: Potential Applications in COVID-19

Cissampelos Pareira Linn: Natural Source of Potent Antiviral Activity Against All Four Dengue Virus Serotypes

Ethnopharmacological Uses of Embelia Ribes Burm. F.-a Review

Screening of Anti-Dengue Activity in Methanolic Extracts of Medicinal Plants

Evaluation of Natural Products as Inhibitors of Human Immunodeficiency Virus Type 1 (HIV-1) Reverse Transcriptase

Antibacterial and Anti-Inflammatory Activities of Anacardium Occidentale Leaves and Bark Extracts

Curcumin and Boswellia Serrata Gum Resin Extract Inhibit Chikungunya and Vesicular Stomatitis Virus Infections In Vitro

Anti-Dengue and Anti-Chikungunya Activities of Plants Frontiers in Cellular and Infection Microbiology | www.frontiersin.org

Analgesic and Anti-Inflammatory Effects and Safety Profile of Cucurbita Maxima and Cucumis Sativus Seeds

Screening and Identification of Lassa Virus Entry Inhibitors From an FDA-Approved Drug Library

The Green Tea Catechin, Epigallocatechin Gallate Inhibits Chikungunya Virus Infection

We thank the Director, ICMR-NIV for encouragement.

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fcimb.2022.866452/ full#supplementary-material

Supplementary Figure 1 | Effect of different plant extracts and pure compounds on cell viability as measured by MTT assay. The results are expressed as mean percent cell viability ± standard error. The experiments were done in triplicates at two independent time points. Cytotoxic concentration that causes 50% cell death (CC50 values) were also provided.

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.